Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
The results of a case study in the March issue of Evidence-Based Diabetes Management™ were summarized in an article on PatientEngagementHIT.com. “Making Diabetes Self-Management Education Patient-Centered: Results From a North Carolina Program” detailed a 4-step approach to patient engagement that resulted in improved glycemic control. “The program’s success highlights the importance of patient education, behavior change, and patient feedback in supporting chronic disease management,” the summary article explained.
An article on Healio’s Ocular Surgery News site encouraging ophthalmologists to pursue business education cited a commentary in the June 2016 issue of The American Journal of Managed Care® (AJMC®) titled “When Doctors Go to Business School: Career Choices of Physician-MBAs.” The authors found that physicians who earn a Master of Business Administration degree often “divert their primary professional focus away from clinical activity.” According to the Healio article, that finding is likely due to the wider range of opportunities and leadership positions made possible with a business degree.
Tuesday’s e-mail newsletter from OBR Daily featured an AJMC® contributor piece in its Oncology Business & Policy News Headlines section. Authored by contributor Kelly Price, “The Oncology Care Model: What to Expect in the First Data Feed” outlined what participants in this new alternative payment model will likely see when the first performance data is released later in March. Price explained that practitioners should keep an open mind and “be ready to reassess and modify their approaches” in response to the information.
Also on Tuesday, the National Pharmaceutical Council’s daily e-newsletter highlighted an AJMC® newsroom article, “VBID Benefit Helps Patients Maintain Adherence After Switch to High-Deductible Plan.” The story discussed recent research on the effectiveness of a value-based insurance design (VBID) benefit among enrollees who were switched to a high-deductible plan. “After the switch to the deductible plan, adherence among the patients without the VBID benefit dropped from 76.1% to 73.8%, while adherence remained steady among those with the VBID benefit,” the article stated.
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
ERISA Industry Committee Sues Minnesota Over PBM Law
January 3rd 2025The Employee Retirement Income Security Act (ERISA) Industry Committee filed a legal challenge against the Minnesota Department of Commerce, arguing that Minnesota’s Pharmacy Benefit Manager (PBM) Licensure and Regulation Act illegally interfered with employer-sponsored health plans by restricting plan design options and increasing costs.
Read More
HS Treatment Goals: Better Quality of Life, Not Just Control
January 3rd 2025For part 3 of our discussion with Chris Sayed, MD, we tackle several important topics in the hidradenitis suppurative (HS) and inflammatory disease space: patient quality of life, medication and treatment goals, and the possibility of a cure.
Read More